COLL vs IP · P/E 17, rev $181.9M vs P/E 43, $26.62B cap
Collegium Pharmaceutical Inc (COLL) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
IP does not have a complete income-statement cache yet.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the COLL and IP stock pages for the full models.
Not investment advice.